Myeloid dendritic cells in HIV-1 infection
Myeloid dendritic cells in HIV-1 infection
复制标题
DOI:
10.1097/coh.0b013e3283499d63
复制
发表时间:
2011-09-01
影响因子:
4.1
通讯作者:
Robbiani, Melissa
中科院分区:
文献类型:
--
作者:
Derby, Nina;Martinelli, Elena;Robbiani, Melissa
Purpose of reviewMyeloid dendritic cells (mDCs) are pivotal players in HIV-1 infection. They promote transmission and spread and at the same time are critical for recognizing HIV-1 and initiating immune responses to fight infection. Notably, their immunostimulatory capabilities can be harnessed to design better HIV-1 vaccines. In this review, advances in these areas of mDC-HIV-1 interactions are summarized.Recent findingsNew insights into HIV-1-induced dysfunction of mDCs and dysfunctional mDC effects on other cell types, as well as novel mechanisms of viral sensing by mDCs and their evasion by HIV-1, have been uncovered. These results emphasize the importance of mDCs in protection against HIV-1 infection. Targeting mDCs with vaccines and tailored adjuvants may improve the quality and anatomical location of elicited immune responses.SummaryUnderstanding the multiplicity of HIV-1-dendritic cell interactions together with the numerous advances in targeted therapy and vaccination will help in the rational design of approaches to treat and block infection.